News | RIVM

Chikungunya infections in the Caribbean region

Since August 2014, there has been an increase in the number of Chikungunya patients in the Caribbean region. Travellers who visit the region can become infected there.

Dr. Els van Schie new director of Environment and Safety

Dr. Els van Schie has been appointed RIVM Director of Environment and Safety as from 1 February 2015. She will succeed Dr. Marcel van Raaij and interim director Dr.

Release of QMRAspot v2 for quantitative microbial risk assessment of drinking water

RIVM has developed a new version of QMRAspot (2.0), a user-friendly computational tool to calculate the risk of becoming infected by pathogenic microorganisms in drinking water.

Annoyance and health effects due to European transportation noise

At least 20 million adults in Europe are annoyed by transportation noise in agglomerations, from motorways, airports or railways.

Statistical Program to Assess Dietary Exposure now available

The Statistical Program to Assess Dietary Exposure (SPADE), developed by RIVM, is now available.

Patient in Radboudumc not contaminated with the Ebola virus

The patient, who was admitted in the Radboud univerisity medical center over the past few days because of a suspected Ebola infection, was proven not to be infected.

Outbreak of avian influenza A (H5N8) in Dutch poultry

In November 2014 avian ‘flu has been detected on poultry farms in the Netherlands.

Promising biobased alternatives to substances of very high concern

There are many possible biobased alternatives to substances of very high concern (SVHC). Some are even ready to be deployed right away.

Partnering as effective strategy to bring new drugs to European market

Combining strengths in drug discovery and development by partnering with a medium- or large-sized pharmaceutical company increases the likelihood of success in bringing new products to the market f